Keeping funding for the DoD’s prostate cancer research initiatives on track

Yesterday, the U.S. Senate approved legislation that will probably keep funding for the Prostate Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Program fully intact for 2013 (subject, of course, to the issue of “sequestration” — otherwise known as “the S word”). However, we need help for 2014! … READ MORE …

Current status of proposed funding for the DoD PCRP in FY 2012

An amendment  to the Defense Appropriations Act offered by Congressman Cliff Stearns (R, FL) on the floor of the House of Representatives yesterday has added back $16 million to the Department of Defense’s Prostate Cancer Research Program (PCRP). The amendment was passed by a voice vote and supported by members of both political parties. … READ MORE …

It’s time to badger Congress — yet again, pretty please!

Many readers will already have seen the report we posted about Senator McCain’s desire to eliminate the Prostate Cancer Research Program within the Congressionally Directed Medical Research Program (CDMRP) — one of the most successful prostate cancer research initiatives. Now you can work with the rest of the advocacy community to counter this. … READ MORE …

48 hours at the IMPaCT symposium in Orlando: Part III

So the question any smart prostate cancer patient should ask himself — especially if he has any degree of good scientific education — is, “How do I get myself invited to the next IMPaCT meeting?” … READ MORE …

48 hours at the IMPaCT symposium in Orlando: Part I

Most medical-scientific meetings that deal (at least in part) with prostate cancer are inhabited by academic scientists, clinicians, and various types of representative of commercial companies. … READ MORE …

Agenda/abstracts for IMPaCT meeting available on line

Every two years, the Prostate Cancer Research Program of the Department of Defense’s Congressionally Directed Medical Research Program holds the “Innovative Minds in Prostate Cancer Today” or IMPaCT meeting. The next such meeting will be held on March 9 to 12 this year in Orlando, Florida. … READ MORE …

House to hold CDMRP hearing, including prostate cancer testimony

The Appropriations Defense subcommittee of the U.S. House of Representatives is to convene a hearing tomorrow (May 20, 2010), featuring public testimony regarding prostate cancer research within the Congressionally Directed Medical Research Program (CDMRP). … READ MORE …